The layoffs at the gene therapy company are part of restructuring of Spark Therapeutics by its owner, Roche Group.

The major workforce overhaul comes a month after parent company Roche deemed the cell and gene therapy firm a financial loss.

Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...